Galleri multi-cancer screening available to Curative members
Prioritizing our members' health and the benefits of proactive screenings, Curative is proud to offer eligible members aged 50 and older no-cost access to the Galleri® multi-cancer early detection test from GRAIL. This groundbreaking test detects a shared signal across more than 50 types of cancer using a single blood sample. Additional testing is required to confirm a diagnosis.
Key benefits of Galleri cancer screening
Key benefits of Galleri cancer screening
The Galleri test looks for a signal associated with active cancer and does not predict your future genetic risk for cancer. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. False positive and false negative results do occur. Galleri should be used in addition to screening tests your healthcare provider recommends.
Screening for more cancers
Added to recommended screening, the Galleri test improves your chance
to find cancer early. It detects a signal shared by dozens of cancers
including many that don't have screening tests.
Testing with ease
Screen with a simple blood draw easily added to your cancer screening plan. No fasting or preparation required. Test requires a prescription from an independent telemedicine provider.
Actionable Results
If a cancer signal is found, results can predict the tissue type or organ associated with the cancer signal. This helps your healthcare provider
guide next steps to determine if cancer is present.
Who is eligible?
All Curative members and their dependents must meet the following eligibility requirements as determined for this program.
Active Curative plan members residing in the United States who have completed their annual Baseline Visit or are within their initial 120-days of plan activation date
Aged 50 years old and older
Not currently pregnant
Not currently undergoing active cancer treatment, though history of cancer* with treatments completed at least 5 years ago is permitted
Curative Testing Process
How do I take the test?
How do I take the test?
Note: No out-of-pocket costs contingent on completion of your Curative Baseline Visit within 120 days of plan activation date. If the Baseline Visit is not completed within the first 120 days of plan activation date, members and dependents completing the test after that time period may be subject to the allowed amount of the Galleri test ($699), depending on how much of their deductible is outstanding. The out-of-pocket cost of the Galleri test will be applied to any outstanding deductible.
Request the test
Click here to create a Galleri portal account and complete an online test request, which includes questions about your medical history (about 10 minutes).
An independent telemedicine provider will review your request.
Receive a collection kit and provide your sample
If the telemedicine provider confirms you're eligible and that Galleri is appropriate for you, they will order the test.
You can schedule a blood draw at a GRAIL blood draw partner and we will ship you a Galleri collection kit for your appointment. The trained technician that draws your blood sample will ship the kit back to the GRAIL lab.
Receive your results
The ordering telemedicine provider will share your test result when ready — about 2 weeks after your blood draw sample arrives at the GRAIL lab.
Get Support
Get Support
For questions about the Galleri test and the Galleri blood draw event, please contact GRAIL Customer Service at 833−694−2553 or by email at customerservice@grail.com.
For questions regarding your Curative plan please contact Member Services at 855-428-7284.
Important Safety Information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Cancer Signal Detected” does not rule out cancer. A test result of “Cancer Signal Detected” requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory / Test Information
GRAIL’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. GRAIL’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.